Difference between revisions of "FOXD2-AS1"
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Annotated Information== | ==Annotated Information== | ||
[[File: LncRNA FOXD2-AS was highly expressed in NSCLC tumors.jpg|right|thumb|400px|'''LncRNA FOXD2-AS was highly expressed in NSCLC tumors''' <ref name="ref1" />.]] | [[File: LncRNA FOXD2-AS was highly expressed in NSCLC tumors.jpg|right|thumb|400px|'''LncRNA FOXD2-AS was highly expressed in NSCLC tumors''' <ref name="ref1" />.]] | ||
| − | [[File: FOXD2-AS1 regulates Wnt | + | [[File: FOXD2-AS1 regulates Wnt-catenin signaling in NSCLC cells.jpg|right|thumb|400px|'''FOXD2-AS1 regulates Wnt-catenin signaling in NSCLC cells''' <ref name="ref1" />.]] |
===Approved Symbol=== | ===Approved Symbol=== | ||
| Line 11: | Line 11: | ||
===RefSeq(supplied by NCBI)=== | ===RefSeq(supplied by NCBI)=== | ||
NR_026878 | NR_026878 | ||
| − | |||
| − | |||
===Disease=== | ===Disease=== | ||
Lung cancer | Lung cancer | ||
| Line 20: | Line 18: | ||
===Expression=== | ===Expression=== | ||
| − | lncRNA FOXD2-AS1 had significantly high expression in NSCLC tissues.<ref name="ref1" />.To be specific, high expression of lncRNA FOXD2-AS1 was shown in 23 cases of 45 (53.3%), in which unchanged was revealed in 10 cases (22%) and down-regulation in 12 cases (24%) <ref name="ref1" /> | + | Compared with the adjacent tissues,lncRNA FOXD2-AS1 had significantly high expression in NSCLC tissues.<ref name="ref1" />.To be specific, high expression of lncRNA FOXD2-AS1 was shown in 23 cases of 45 (53.3%), in which unchanged was revealed in 10 cases (22%) and down-regulation in 12 cases (24%) <ref name="ref1" /> |
{| class='wikitable' style="text-align:center" | {| class='wikitable' style="text-align:center" | ||
| Line 34: | Line 32: | ||
==Labs working on this lncRNA== | ==Labs working on this lncRNA== | ||
| − | |||
* Department of Thoracic Surgery, The Second People's Hospital of Liaocheng, Liaocheng, Shandong 252600, China. Electronic address: wchqba@163.com. | * Department of Thoracic Surgery, The Second People's Hospital of Liaocheng, Liaocheng, Shandong 252600, China. Electronic address: wchqba@163.com. | ||
Latest revision as of 11:31, 19 November 2017
Contents
Annotated Information
LncRNA FOXD2-AS was highly expressed in NSCLC tumors [1].
FOXD2-AS1 regulates Wnt-catenin signaling in NSCLC cells [1].
Approved Symbol
FOXD2-AS1 (FOXD2 antisense RNA 1 (head to head))
Synonyms
MGC12982
Chromosome
1p33
RefSeq(supplied by NCBI)
NR_026878
Disease
Lung cancer
Function
Loss- and gain-function assays suggested that FOXD2-AS1 remarkably modulates the tumorigenesis of NSCLC through Wnt/β-catenin signaling.[1] FOXD2-AS1 overexpression promotes NSCLC progression.[1]
Expression
Compared with the adjacent tissues,lncRNA FOXD2-AS1 had significantly high expression in NSCLC tissues.[1].To be specific, high expression of lncRNA FOXD2-AS1 was shown in 23 cases of 45 (53.3%), in which unchanged was revealed in 10 cases (22%) and down-regulation in 12 cases (24%) [1]
| Experiment | Forward primer | Reverse primer |
|---|---|---|
| qRT-PCR | 5'-TGGACCTAGCTGCAGCTCCA- 3' | 5'-AGTTGAAGGTGCACACACTG- 3'[1] |
Labs working on this lncRNA
- Department of Thoracic Surgery, The Second People's Hospital of Liaocheng, Liaocheng, Shandong 252600, China. Electronic address: wchqba@163.com.
